Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dialysis
Businessman Exposed Problems With Quest Subsidiary's Blood Test Kits; Led to $302 Million Settlement
May 2nd, 2009
The impetus for the massive federal investigation that led to today's $302 million settlement by Quest Diagnostics Inc. was a "qui tam" (whistleblower) lawsuit filed by a California businessman and biochemist, the government revealed today. The qui tam lawsuit provided detailed allegations about problems with medical test kits that a Quest subsidiary, Nichols Institute Diagnostics Inc. (NID), manufactured and sold to medical testing labs across the country from 2000 to 2006 despite complaints of inaccurate test results, putting the health of hundreds of thousands of dialysis patients at risk. As a result of the faulty tests, the lawsuit said, some...
Source: Law & Health Weekly (2009-05-02)
|
